Sanofi-Pasteur's Southern Strategy Gets Its Own FDA Advisory Committee
Fluzone remains only flu vaccine on US market with an FDA-approved southern formulation.
You may also be interested in...
Recent and upcoming FDA advisory committee meetings and a summary of topics covered.
Sanofi gets its manufacturing roadmap as advisory committee supported WHO's preferred trivalent and quadrivalent formulations in separate 14-0 votes.
After US FDA's Oncologic Drugs Advisory Committee voted to delay approval of Karyopharm's multiple myeloma drug Xpovio, the company submitted some data from the Phase III BOSTON trial, which prompted the FDA to award an accelerated approval for a narrower indication.